Необязательная аналитика продукта
С вашего разрешения мы используем ограниченную аналитику с защитой конфиденциальности, чтобы понять, какие исследовательские сценарии работают. Мы не используем рекламные трекеры или запись сеансов. Этот выбор можно изменить в настройках. Прочитайте Политику конфиденциальности.
KeyCorp's published Buy conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $21.3B | |
|---|---|---|
| Revenue (ttm) | 7.6B | |
| Net income (ttm) | 2B | |
| EPS (ttm) | $1.82 | |
| Shares out | 1.1B | |
| P/E (trailing) | 11.6x | |
| P/E (forward) | 9.9x | |
| Dividend | $0.82 (3.86%) | |
| Volume | 15,679,438 | |
| Beta | 1.09 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $1.82B | $1.59B | $1.44B | $1.64B | $1.75B | -1.0% |
| Gross profit | $7.46B | $7.03B | $5.73B | $4.06B | $6.97B | -1.7% |
| Operating income | $3.25B | $3.22B | $1.16B | $-306.0M | $2.30B | -8.3% |
| Net income | $2.63B | $1.92B | $967.0M | $-161.0M | $1.83B | -8.6% |
| EPS (diluted) | $2.63 | $1.93 | $0.88 | $-0.32 | $1.52 | -12.8% |
| EBITDA | $3.29B | $3.36B | $1.31B | $-233.0M | $2.33B | -8.3% |
| R&D | — | — | — | — | — | — |
| SG&A | $2.69B | $2.66B | $2.66B | $2.78B | $3.20B | +4.4% |
Recent company headlines from major financial publishers.
The Base scenario reflects the modal expected operating path. Structural fixed-rate repricing across the asset pipeline steadily lifts net interest margin into the guided range by late FY2026. Controlled overhead expansion generates positive operating leverage, advancing diluted EPS toward consensus targets in FY2026 and FY2027. Capital generation funds the planned share repurchase program while maintaining robust regulatory capital ratios.
In the Bull scenario, KeyCorp accelerates fixed-rate asset reinvestment at premium yields while deposit costs fall faster than expected due to disciplined beta management. Commercial borrowing surges across KeyBanc Capital Markets verticals, lifting C&I loan growth and investment banking fees. Operating efficiency improves rapidly, driving ROTCE expansion and supporting enhanced capital return, propelling valuation toward $35.57.
| Ke ↓ / g → | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 7.2% | $25.0 | $26.2 | $27.6 | $29.4 | $31.6 |
| 8.0% | $22.9 | $23.8 | $24.9 | $26.2 | $27.7 |
| 8.7% | $21.2 | $21.9 | $22.8 | $23.7 | $24.8 |
| 9.5% | $19.8 | $20.4 | $21.0 | $21.7 | $22.6 |
| 10.2% | $18.6 | $19.1 | $19.6 | $20.1 | $20.8 |
Upcoming earnings date and setup when available.
Рейтинг, который имело опубликованное в каждом месяце издание исследования. Рейтинг сравнивает цену на дату анализа со справедливой стоимостью; он не показывает, оправдалась ли оценка.
| Год | янв. | февр. | март | апр. | май | июнь | июль | авг. | сент. | окт. | нояб. | дек. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |